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Abstract
Background: The aim of this study was to estimate the prevalence of fibromyalgia, as well as to
assess the major symptoms of this syndrome in an adult, low socioeconomic status population
assisted by the primary health care system in a city in Brazil.
Methods: We cross-sectionally sampled individuals assisted by the public primary health care
system (n = 768, 35–60 years old). Participants were interviewed by phone and screened about
pain. They were then invited to be clinically assessed (304 accepted). Pain was estimated using a
Visual Analogue Scale (VAS). Fibromyalgia was assessed using the Fibromyalgia Impact
Questionnaire (FIQ), as well as screening for tender points using dolorimetry. Statistical analyses
included Bayesian Statistics and the Kruskal-Wallis Anova test (significance level = 5%).
Results: From the phone-interview screening, we divided participants (n = 768) in three groups:
No Pain (NP) (n = 185); Regional Pain (RP) (n = 388) and Widespread Pain (WP) (n = 106). Among
those participating in the clinical assessments, (304 subjects), the prevalence of fibromyalgia was
4.4% (95% confidence interval [2.6%; 6.3%]). Symptoms of pain (VAS and FIQ), feeling well, job
ability, fatigue, morning tiredness, stiffness, anxiety and depression were statically different among
the groups. In multivariate analyses we found that individuals with FM and WP had significantly
higher impairment than those with RP and NP. FM and WP were similarly disabling. Similarly, RP
was no significantly different than NP.
Conclusion: Fibromyalgia is prevalent in the low socioeconomic status population assisted by the
public primary health care system. Prevalence was similar to other studies (4.4%) in a more diverse
socioeconomic population. Individuals with FM and WP have significant impact in their well being.
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Background
Fibromyalgia (FM) is a frequent rheumatologic disorder
worldwide [1-5]. It responds by up of 7% of all primary
care consultations, imposing substantial costs to the sys-
tem [6].
The prevalence of FM ranges from 0.66% to 10.5% [7],
with most studies pointing into a prevalence around 2%
in the adult population. Prevalence is higher in women
(around 3.4%) [8] and in middle-age (5%) [1,4]. Most
studies were conducted in developed countries; studies in
emerging countries or in under-assisted populations are
scarce.
Although the impact of FM in productivity [9,10], disabil-
ity [11,12] and quality of life [13,14] of sufferers is well
documented in the Brazilian population [14,15], only
one study assessed its prevalence. This study was con-
ducted in a single city and reported a prevalence of 2.5%
[4]. Because Brazil is a continental country, other studies
are necessary. A better understanding of the epidemiology
of FM is an important step for planning the health care
system to properly assist this population, assuring
improvements in the quality of care and rational cost-
implementation.
The aim of this study was to estimate the prevalence of FM
and its symptoms in a middle-aged adult population (35–
60 years) registered in the primary health care system of a
city in Brazil (Embu City, São Paulo State). The popula-
tion assisted by this system is of low income. We hypoth-
esized that the prevalence of FM is increased in this low
income population, may be because they are exposed to
several pain risk factors.
Methods
Sample
Our study was conducted in Embu, in the metropolitan
area of São Paulo, Brazil. We chose this city because it has
similar socio-demographic characteristics of São Paulo
city and of other cities in the area. The city has an area of
70 km2, with a population of 207,663 inhabitants. Most
of its population is of low income as per estimates of
Gross Domestic Income (GDI – per capita GDI is 3,000
dollars). The Human Development Index (HDI) is 0.772;
7.7% of the adult population is illiterate; overall, mean
number of school years is 6.5 [16].
Our sample was non-probabilistic; potential participants
were selected from the nine units that form the first access
to public primary health care system, from the Brazilian
Unified Health System, in the city [16]. For individuals of
low-income, the Unified Health System is basically the
only option for health care, also granting access to other
forms of governmental support. For Embu population,
the public health care represents 77% of all health estab-
lishments in the city [16].
Procedures and Methods
For the screening survey, we selected all individuals regis-
tered in the nine primary care units during the year of
2003. Potential participants were 35–60 years in the year
of 2004. In a pilot study we found difficult to conduct
face-to-face interviews with these individuals. Because
73% of the 3,109 registered subjects had telephone at the
time of the survey, we conducted the screening interviews
by phone.
We attempted to contact all 2,269 potential participants.
Around 30% of them could not be contacted because were
not available, even though the calls were done more than
once for each household, and at different times of the day.
The refuse rate was insignificant (>1%). Because our sam-
ple size was estimated as being less than 768, we ended
this screening phase.
The screening phone interviews were conducted by
trained staff (three physical therapists and three students
of physical therapy). They assessed the presence of pain
(yes/no), time of pain (in months), and pain distribution
(which sites of pain). The screening survey intended to
triage individuals with pain as it is typically done in stud-
ies of this nature.
According to the American College of Rheumatology cri-
teria (ACR), respondents were classified as suffering from
widespread pain (WP) when they had pain in the "axial +
upper and lower segment + left and right-sided pain" [17].
Those without WP were classified as having regional pain
(RP – pain not fulfilling the WP criteria) or no pain (NP).
The majority of subjects with pain (92%) had it for more
then three months (chronic pain) (Figure 1).
All 768 respondents were invited to participate in a clini-
cal interview, where they would be assessed using stand-
ardized questionnaires and exams of potential tender
points. Of them, 304 accepted and were seen in one of the
participant's primary care units. The volunteers did not
receive any financial support.
In the evaluation, we obtained socio-demographic data,
as well as pain history. Pain intensity was measured with
the Visual Analogue Scale (VAS). Tender points were
assessed using the Fischer dolorimeter [18], according to
the ACR [17] and Okifuji et al. [19]. Tender points were
defined positive if tenderness was present at 2.6 kg/cm2 of
pressure [20]. Tests were performed by an experienced
physical therapist. Although the ACR criteria recommend
manual pressure for determining tender points, the relia-
bility of this method is questionable [21,22], and assess-BMC Musculoskeletal Disorders 2009, 10:64 http://www.biomedcentral.com/1471-2474/10/64
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ments of pain threshold by dolorimeters have been
suggested [21].
Major FM symptoms were assessed by the Fibromyalgia
Impact Questionnaire (FIQ) [23], which has been validated
for Brazilian Portuguese [24]. Because of the high propor-
tion of individuals with low education, the questions were
supervised by a researcher.
The screening algorithm for the diagnosis of FM consid-
ered the presence and number of tender points and the
pain features, as proposed by the ACR (Figure 1).
This study was reviewed and approved by the local Ethics
Committee and informed consent was obtained.
Data Analysis
The data were coded using Excel for Windows (version
2002) and Analyze-it (version 2000), MINITAB 14, SAS
System V8 and Statistica V7.
The prevalence of FM was estimated based on Bayesian
Analysis. By using this method, phone interviews could be
used to estimate the prevalence of widespread chronic
pain. Furthermore, this analysis better address several of
the biases in clinical research, allowing the use of a bigger
sample (n = 768) in many of the estimates [25].
Data obtained from the FIQ were tested for normality
using the Shapiro-Wilk test. Groups were compared using
the Kruskal-Wallis Anova and multiple variance analysis.
The significance level was 0.05.
Flow chart for inclusion procedure and distribution of subjects among groups Figure 1
Flow chart for inclusion procedure and distribution of subjects among groups.BMC Musculoskeletal Disorders 2009, 10:64 http://www.biomedcentral.com/1471-2474/10/64
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Results
Most of the 768 subjects participating in the screening
phone interview were women (77%), married and of low
educational level. Table 1 presents demographic data for
participants in the phone and clinical assessments.
Using the Bayesian approach, the prevalence of wide-
spread chronic pain was 24%, with a 95% credibility
interval (CI) [21%; 27%]. Among individuals with WP the
prevalence of FM was 18% (95% CI = 11% – 25%). For
this calculation, the Beta distribution parameters were 0.1
to 0.4 (a priori) and 19.1 to 87.4 (a posteriori). The beta dis-
tribution assumes continuous.. probability distributions
defined on the interval [0, 1]. The a priori parameters was
defined based on known proportions of WP and FM and
the a posteriori parameters was calculated based on the
number of FM and WP subjects. Accordingly, the preva-
lence of FM was defined as a function of WP probability
and proportion of individuals with WP who also
endorsed FM. It was 4.4% (95% CI = 2.7%–6.3%).
Fibromyalgia symptoms
The items of the FIQ questionnaire were significantly dif-
ferent among the groups, except for physical function and
work missed. Individuals with FM were the most
impaired. However, in multiple variance analysis, FM and
WP were similar, and significantly different than RP and
NP.
Individuals with NP had significantly less impairment, as
compared to the other groups, in several domains includ-
ing working for job ability, pain, fatigue, morning tired-
ness, stiffness and depression. Individuals with RP were
less impaired than WP in the domains of well, fatigue,
morning tiredness and anxiety, and different from FM for
fatigue and stiffness. Individuals with WP and FM had no
significant differences in the assessed domains in multiple
variances analysis. Pain, as assessed by the VAS, was signif-
icantly higher in the FM group, followed by in those with
WP (p < 0,001) (Table 2).
Discussion
In our study, the prevalence of FM in a middle-aged adult
population of a low socioeconomic population was 4.4%
and all cases were women. The prevalence was higher than
what has been reported elsewhere. In most studies the
prevalence ranges from 2% to 4% [8,13], but important
discrepancies exist [26-28].
The high prevalence of FM found in our study may be
explained by the age of our inclusion sample (35 – 60
years old), when fibromyalgia is more frequent, as shown
Table 1: Demographic data of participants in the phone interview (n = 788) and on the in-person assessments (n = 304).
Phone Interview No Pain Regional pain Widespread pain
(n = 185) (n = 388) (n = 195)
Gender
Female 123 (66%) 294 (76%) 173 (88%)
Male 62 (34%) 94 (24%) 22 (12%)
Age (years)
Female 57.5 (6.8) 48.8 (7.1)) 48.8 (6.7)
Male 47.8 (8.1) 49.5 (7.5) 51.5 (7.2)
Clinical Assessment No Pain Regional pain Widespread pain Fibromyalgia
(n = 47) (n = 151) (n = 87) (n = 19)
Gender
Female 30 (64%) 117 (77%) 78 (90%) 19 (100%)
Male 17 (36%) 34 (23%) 9 (10%) 0 (0%)
Age (years) (Mean/SD)
Female 47.4 (5.6) 49.6 (6.9) 49.1 (6.8) 50.8 (6.5)
Male 50.8 (7.4) 51.6 (6.0) 51.4 (7.3) -
BMI* (kg/m2) (Mean/SD)
Female 28.1 (5.9) 27.8 (6.1) 27.4 (4.9) 27.4 (4.5)
Male 27.5 (4.4) 27.0 (3.5) 27.1 (2.5) -
Total 27.9 (5.3) 27.6 (5.5) 27.3 (6.8) 27.4 (4.5)
Occupation
Retired 2 (4.3%) 24 (15.9%) 12 (13.7%) 4 (21.1%)
Unemployed 2 (2.3%) 6 (4.0%) 4 (8.5%) 1 (5.3%)
Household work 24 (44.2%) 66 (43.7%) 44 (56.4%) 10 (52.7%)
People who work mainly standing up** 17 (35.1%) 41 (27.2%) 21 (24.1%) 4 (21.1%)
People who work mainly sitting down*** 6 (12.8%) 12 (7.9%) 6 (6.9%) 0 (0.0%)
** For example: cooker, bodyguard, carpenter etc. *** For example: driver (bus, taxi), secretary etc.BMC Musculoskeletal Disorders 2009, 10:64 http://www.biomedcentral.com/1471-2474/10/64
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in studies that enrolled other age categories, such as 18 or
20 and 70 or 80 years old [1,4,8,13]. Indeed, studies con-
sistently show that FM is more common in middle-aged
individuals (Table 3) and is less prevalence in the young-
est and the elderly. Carmona et al. 2001 [1] found preva-
lence of FM being 1.6% from 30–39 years, increasing to
4.9% in the forth decade and then decreasing to 3.7%
between 50 and 59 years old. Senna et al., in a study con-
ducted in Brazil found the prevalence of 2.5% [4] How-
ever, in those of 35–54 years old, the prevalence was 5.5%
[4.2%; 6.8%], numerically higher than ours (4.4%, 95%
CI = 2.6%–6.3%).
Although the prevalence of FM in our casuistic was very
similar to what had been found in other studies, we found
a higher prevalence of widespread chronic pain (24%,
95% CI = 21–27%). Croft et al. [30] reported prevalence
of 11.2%, later confirmed by Storozhenko et al. [31]. This
discrepancy may be due to the fact we enrolled a high-risk
population for chronic pain. Both middle age [32] and
female gender are known risk factors for chronic pain [33-
35], determined by biological [36] and social factors
[32,37,38]. Increased weight is also a risk factor for pain,
especially in women [32]. Furthermore, low-income indi-
viduals are more likely to work in manual functions,
which may also facilitate injuries and pain. Wijnhoven et
al. [39] related that non-paid work (e.g. household work)
is per se a risk factor for pain [33,36]. Other studies report
an inverse association between education and chronic
pain [33,36]. Accordingly, our sample should be consid-
ered of high risk for widespread chronic pain (as shown in
Table 1).
The last assumption is supported by the fact that several
studies showed an inverse relation between presence of
musculoskeletal symptoms and socioeconomic status
[40]. However, of interest is that these factors did not
determine a higher prevalence of FM in our study.
Another factor explaining the high prevalence of wide-
spread chronic pain was the screening interview being
conducted over the telephone, forcing reliance on self-
report.
Table 2: Fibromyalgia symptoms assessed by the Fibromyalgia Impact Questionnaire (FIQ) and by the Visual Analogue Scale (VAS).
SYMPTOMS No Pain Regional Pain Widespread Pain Fibromyalgia
(n = 47) (n = 151) (n = 87) (n = 19) P value
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Pain VAS 2.2 (3.0) 5.1 (3.2) 6.1 (2.9) 7.9 (1.8) <0.001*
FIQ
Physical Function 9.3 (5.9) 11.2 (5.8) 10.8 (5.4) 12.4 (7.7) 0.12
Feeling Well 4.8 (2.7)a, c 3.7 (2.8)b 2.5 (2.5)b, c 2.0 (2.6)a <0.001*
Work Missed 0.0 (0.1) 0.2 (0.9) 0.1 (0.6) 0.0 (0.0) 0.26
Job Ability (VAS) 2.4 (2.8)a 5.1 (3.1)b 5.7 (3.0)b 6.6 (2.8)a <0.001*
Pain (VAS) 2.2 (2.8)a 5.7 (3.0)b 6.3 (2.5)b 7.7 (1.8)a <0.001*
Fatigue (VAS) 3.1 (3.1)a, c, d 5.7 (2.9)b, d 6.9 (2.5)b, c 7.5 (2.3)a <0.001*
Morning Tiredness (VAS) 2.3 (2.3)b, d, e 4.1 (3.1)a, c, e 5.8 (2.8)c, d 6.6 (3.0)a, b <0.001*
Stiffness (VAS) 1.8 (2.3)b, c, d 5.3 (7.9)a, d 5.9 (3.0)c 7.5 (2.5)a, b <0.001*
Anxiety (VAS) 4.3 (3.3)a, c, d 6.3 (2.9)b, d 7.6 (2.3)b, c 7.6 (2.5)a <0.001*
Depression (VAS) 3.4 (3.1)a, b, c 5.4 (3.2)c 6.2 (2.8)b 7.0 (2.5)a <0.001*
* statistically different for α = 0,05, Kruskal Wallis Anova
a, b, c, d, e in pairs identify which groups are statistically different between, Multiple Comparison Test
Table 3: Fibromyalgia prevalence in literature in populations from 30 and 59 years.
Authors gender Prevalence for age classes (years)
30–39 35–44 35–54 45–54 40–49 50–59
Carmona et al.[1] Both 1.6% - - - 4.6% 5.7%
Senna et al.[4] Both - - 5.5% - - -
Topbas et al.[29] Female 3.5% - - - 5.0% 10.1%
Wolfe et al.[8] Female 2.0% - - - 3.4% 5.6%
White et al.[13] Female - 5.5% - 6.6% - -BMC Musculoskeletal Disorders 2009, 10:64 http://www.biomedcentral.com/1471-2474/10/64
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We also assessed the main symptoms of FM in the popu-
lation. Although not considered in the ACR criteria, they
define the essence of the syndrome [41,42] and add to its
disability [13] and negative impact on quality of life [14].
We used the FIQ to assess the impact of FM symptoms in
individuals not fulfilling de ACR criteria. Some symptoms
were common in the other groups as well. As compared to
individuals with NP, there were significant differences for
all FIQ items, except for "physical function" and "work
missed. However, the multiple variances analysis showed
that, for the majority of FIQ items, NP and RP were similar
and statistically different than the groups WP and FM
(which, in turn, where not different).
Accordingly, we notice that although WP and FM have dif-
ferent criteria and definitions, the intensity of the symp-
toms is similar. It may be that individuals with WP, due to
the physical and emotional aspects of pain [43], decrease
physical and social activities and become more sedentary
[44]. Eventually this may predispose to anxiety, depres-
sion and tiredness which, according to Croft et al. [30],
may then predispose to FM.
Alternative, it may be that many individuals with WP have
unclassified FM. As with FM, individuals with WP have
chronic pain in different regions of the body. However,
they have less than 11 tender points. It has been suggested
that experienced rheumatologists often diagnose WP as
FM, even in the absence of tender points [45]. Indeed,
recent discussions question whether the ACR Criteria ade-
quately capture the essence of FM. Symptoms perhaps
could be included in the diagnosis again [41,42] as had
been used by Smythe & Modollfsky [46].
Being so prevalent in the population assisted by the pri-
mary care public system, WP and FM are certainly of eco-
nomic importance, suggesting that the health
professionals should be careful in assessing these disor-
ders. Future studies should be developed to assess the ade-
quacy of the ACR criteria in the primary care.
Our study has limitations. Our sample was formed among
people registered in the Public Health Care System of
Embu, and the data may not be extrapolated. Several
biases may exist in the screening interview including lack
of telephone or inability to be contacted. The screening
survey was established based on methodological and eco-
nomical feasibility. Some of these biases were at least par-
tially addressed by the Bayesian Analyses. Nonetheless, we
suggest that future studies addressing the low-income
population account for inherent problems of dealing with
this stratum, including education limitations (difficulties
in understanding certain questions or demands, need for
cross-cultural adaptation of the instruments, etc). Finally,
it may be that the personal assessments should be done in
the household of the participants, to mitigate economic
barriers (e.g. lack of money for transportation, need to
work on weekends). Nonetheless, our findings should not
be discrepant to what happens in similar cities.
Conclusion
Our findings point for the importance of FM to the public
health system, and highlight the need of preparing public
policies to prepare the system to the demand posed by
FM, and also to provide adequate care aiming to improve
the daily life activities and the quality of life, as recently
suggested by Blyth [47]. These policies are especially
important for people of low income, who depend on the
government health care system. Because classification of
FM was done using the ACR Criteria proposed in 1990,
future studies are necessary to discuss the better criteria to
account for the syndrome complexity.
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